Literature DB >> 28342980

Muscarinic receptor mediated signaling pathways in hepatocytes from CCL4 - induced liver fibrotic rat.

Lin Luo1, Chenghao Xi2, Tingting Xu2, Gaoshan Zhang2, E Qun3, Wei Zhang4.   

Abstract

The pathological changes of parasympathetic nerves are considered as an independent prognostic factor of the survival rate for patients with chronic liver disease. The non-selective muscarinic acetylcholine receptors (mAchR) agonists and antagonists can affect the proliferation of hepatocytes, but little is known about the role of mAChR in hepatocytes and hepatic fibrosis and the signaling pathway of this receptor in regulation of hepatocytes remains elusive. Here, 3ml/kg 40% carbon tetrachloride (CCL4) was given to induce hepatic fibrosis in rats and the hepatocytes were isolated to investigate the expression of mAchR and the cell signaling pathways which were involved in. Compared with the normal state, the expression levels of m1, 3, 5 in fibrotic hepatocytes (FHC) and the cells treated with 10μM pilocarpine (Pi) were obviously increased, while decreased in m2,4. Pi could increase the value of alanine aminotransferase (ALT), hydroxyproline (Hyp), decrease albumin (ALB) and cell viability, while atropine could ameliorate fibrotic hepatocytes fuction. The p-AKT, p-ERK, p- JNK and p-P38 increased in Pi group or FHC group, but the inhibitors of PI3K, MAPK and PKC could reverse the Pi action and improve the FHC fuction. In this study we found that mAchR played an important role in the regulation of hepatic fibrosis process and the PKC, ERK, P38 and PI3K/AKT signaling pathways involved in the parasympathetic excitation mediated by mAchR.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Cell signaling pathway; Hepatic fibrosis; Hepatocytes; Muscarinic acetylcholine receptors

Mesh:

Substances:

Year:  2017        PMID: 28342980     DOI: 10.1016/j.ejphar.2017.03.047

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

Review 1.  Recent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin.

Authors:  Jingyao Zhang; Yun Chen; Huiqin Luo; Linlin Sun; Mengting Xu; Jin Yu; Qigang Zhou; Guoliang Meng; Shengju Yang
Journal:  Front Pharmacol       Date:  2018-10-25       Impact factor: 5.810

Review 2.  The protective effect of hederagenin on renal fibrosis by targeting muscarinic acetylcholine receptor.

Authors:  Wei Yang; Lijuan He
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.